Add Company
Join Now

Boehringer Laboratories Revenue and Competitors

License our Company Data API

Phoenixville, PA USA

Location

N/A

Total Funding

Medical

Industry

Estimated Revenue & Valuation

  • Boehringer Laboratories's estimated annual revenue is currently $7.5M per year.(i)
  • Boehringer Laboratories's estimated revenue per employee is $84,270

Employee Data

  • Boehringer Laboratories has 89 Employees.(i)
  • Boehringer Laboratories grew their employee count by 20% last year.

Boehringer Laboratories's People

NameTitleEmail/Phone
1
VP R&D / EngineeringReveal Email/Phone
2
VP SalesReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Director MarketingReveal Email/Phone
5
IT ManagerReveal Email/Phone
6
Strategic Development ManagerReveal Email/Phone
7
Engineering Manager, QA, RA, Sustaining EngineeringReveal Email/Phone
8
Area Sales ManagerReveal Email/Phone
9
Area Sales ManagerReveal Email/Phone
10
Area Sales ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A24-8%N/AN/A
#2
N/A327%N/AN/A
#3
$3.5M15-40%N/AN/A
#4
$75M540%N/AN/A
#5
$75M1981%N/AN/A
#6
$3.5M360%N/AN/A
#7
N/A8920%N/AN/A
#8
N/A23035%N/AN/A
#9
N/A819%N/AN/A
#10
$35M1585%N/AN/A
Add Company

What Is Boehringer Laboratories?

For almost 50 years, Boehringer Laboratories, LLC has provided expertly engineered solutions in respiratory therapy, suction controls, and minimally invasive surgery. We have introduced many innovations in these fields and have been awarded numerous U.S. and foreign patents. Our ViSiGi 3D® minimally invasive device is the first and leading sleeve calibration system in the world intended for Bariatric procedures. We take great pride in our ability to innovate and provide our customers with safe, reliable, and cost-effective products.

keywords:N/A

N/A

Total Funding

89

Number of Employees

$7.5M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A8920%N/A
#2
$38.8M1107%N/A
#3
$32.5M1120%N/A
#4
$22.1M12313%N/A
#5
$43.6M220N/AN/A